# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-071349
Filing Date
2025-05-14
Accepted
2025-05-14 16:02:14
Documents
65
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vor-20250331.htm iXBRL | 10-Q | 1447747
2 | EX-31.1 | vor-ex31_1.htm | EX-31.1 | 17188
3 | EX-31.2 | vor-ex31_2.htm | EX-31.2 | 17174
4 | EX-32.1 | vor-ex32_1.htm | EX-32.1 | 16823
| Complete submission text file | 0000950170-25-071349.txt |  | 6511453

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | vor-20250331.xsd | EX-101.SCH | 906459
67 | EXTRACTED XBRL INSTANCE DOCUMENT | vor-20250331_htm.xml | XML | 1175528

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 25945157
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)